Diagnostics & Devices
Pediatric diagnostics and devices face a harder regulatory and commercial path than adult tools — smaller populations, age-specific validation requirements, and Medicaid-dominant reimbursement. The companies that clear those hurdles are building durable moats.
Coverage
Sibel Health Receives $5M Gates Foundation Grant + FDA Clearance for ANNE Maternal
Sibel Health received a $5M Gates Foundation grant alongside FDA 510(k) clearance for its ANNE Maternal wireless monitoring platform — combining non-dilutive capital, regulatory clearance, and a globally-oriented funder in the same announcement window.
FDA Approves Otarmeni for Genetic Hearing Loss
FDA approved the first dual AAV vector-based gene therapy and first approved gene therapy for inherited hearing loss in children — a landmark for pediatric-specific therapeutics.
FDA 510(k) Clearance: EarFlo Pediatric Ear Pressure Equalization Device
A new FDA-cleared device for pediatric ear pressure equalization signals continued regulatory activity in pediatric-specific device categories.
Related Resource
AI in Pediatric Diagnostics
Narrow clinical AI in high-acuity settings — particularly the NICU — represents the most credible pediatric-native AI story. Read the full AI in Pediatrics overview for context on where machine learning is landing in diagnostics.
Read AI in Pediatrics →